Application 065429
- Type
- ANDA
- Sponsor
- ORCHID HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFDINIR | CEFDINIR | FOR SUSPENSION;ORAL | 125MG/5ML | No | No |
| 002 | CEFDINIR | CEFDINIR | FOR SUSPENSION;ORAL | 250MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065429-001 | CEFDINIR | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | |
| A065429-002 | CEFDINIR | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065429-001 | AB |
| A065429-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065429-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065429-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-07-18 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065429-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065429-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065429-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065429-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065429-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065429-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065429-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065429-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065429-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065429-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065429-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065429-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065429-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065429-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065429-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065429-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065429-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065429-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065429-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065429-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065429-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065429-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065429-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065429-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065429-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065429-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065429-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065429-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065429-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065429-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065429-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065429-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065429-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065429-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065429-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065429-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065429-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065429-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065429-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065429-002 | AB | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | Northwind Health Company, LLC | 1d0d50ba-8c2b-855c-e063-6394a90a5c7d | 2026-07-09 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | 63d2f931-6896-47e5-905e-4f812d6cb105 | 2026-06-01 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | REMEDYREPACK INC. | a8029f7c-6353-46db-8c8c-c86a9485a14f | 2026-05-15 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals, Inc. | 5128dc70-f3cd-25c0-e063-6294a90aa52f | 2026-05-06 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 3714d558-cbaa-42e8-831b-ffbbc951ebf2 | 2026-04-21 | Warnings | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 5b6c1b5d-a1d5-4e08-9077-2af3f38fea4e | 2026-03-24 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | c3892cd7-0e98-4ba3-a845-4aedf6c2a830 | 2026-03-24 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 2da6eb80-63b0-4377-8d7b-865733ebbab1 | 2026-03-24 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 0d1212c9-604f-4999-8f7d-e7cf300705ef | 2026-03-24 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 2e384d98-642e-4841-9f62-fcea4c242f4e | 2026-03-24 | Warnings, Adverse reactions | cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals, Inc. | 8787ea15-bf90-4178-9b0f-08b075f1aa3d | 2026-03-24 | Warnings | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | c23af6af-a97b-b98d-e053-2995a90ae780 | 2026-03-13 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| cefdinir | CEFDINIR | A-S Medication Solutions | 2bd2101c-511d-45a9-b1d8-a45ed40c5b80 | 2026-03-12 | Warnings, Adverse reactions | cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | a5f028d5-ab33-491e-a385-56e79e165150 | 2026-02-24 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | REMEDYREPACK INC. | eb354221-c476-41cb-ad87-52423f81d698 | 2026-01-28 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | AvKARE | 1acc5d17-10a4-e23d-e063-6394a90a52c3 | 2026-01-13 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 17b4e82f-4169-4ab9-bd4a-79781a71e160 | 2025-12-19 | Warnings | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | 9ba5cb2d-6272-27de-e053-2995a90a58c8 | 2025-12-03 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | Major Pharmaceuticals | a0934baf-4745-4546-a63a-d4a660a188b3 | 2025-10-23 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | e296387e-eb20-4451-a184-f91748a4e9c7 | 2025-10-17 | Warnings, Adverse reactions | Cefdinir CEFDINIR |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42043-251 | Cefdinir | Cefdinir | OrchidPharma Inc | ANDA | Current |
| 42043-252 | Cefdinir | Cefdinir | OrchidPharma Inc | ANDA | Current |
| 68071-3393 | Cefdinir | Cefdinir | NuCare Pharmaceauticals,Inc. | ANDA | Current |
| 68071-4236 | Cefdinir | Cefdinir | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-6840 | Cefdinir | Cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-6840 | Cefdinir | Cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |